Internal Medicine
Online ISSN : 1349-7235
Print ISSN : 0918-2918
ISSN-L : 0918-2918
ORIGINAL ARTICLES
ABO Blood Type and the Long-term Outcomes of Pancreatic Cancer
Yoshinori Tanaka, Teru Kumagi, Takashi Terao, Taira Kuroda, Tomoyuki Yokota, Nobuaki Azemoto, Yoshiki Imamura, Kazuhiro Uesugi, Yoshiyasu Kisaka, Naozumi Shibata, Mitsuhito Koizumi, Yoshinori Ohno, Kozue Kanemitsu, Atsushi Yukimoto, Kazuhiro Tange, Mari Nishiyama, Teruki Miyake, Hideki Miyata, Hiroshi Ishii, Masanori Abe, Yoichi Hiasa, on behalf of the Ehime Pancreato-Cholangiology (EPOCH) Study Group
Author information
Keywords: pancreatic cancer, ABO blood type, long-term outcomes, tumor behavior
JOURNAL OPEN ACCESS

2020 Volume 59 Issue 6 Pages 761-768

Details
Download PDF (548K)
Download citation RIS

(compatible with EndNote, Reference Manager, ProCite, RefWorks)

BIB TEX

(compatible with BibDesk, LaTeX)

Text
How to download citation
Contact us
Abstract

Objective The long-term effect of the ABO blood type on the clinical course of patients with pancreatic cancer (PC) is inconclusive. This study aimed to determine whether or not the ABO blood type influences the long-term outcomes of PC in Japanese patients.

Methods The medical records of Japanese patients with PC were reviewed. Data, including the age, sex, and outcomes, from the Ehime Pancreato-Cholangiology Study Group were analyzed.

Results The mean age of the 406 patients was 71.0±10.5 years, and 220 (54.2%) were men. A total of 44.6%, 20.7%, 22.4%, and 12.3% had blood type A, B, O, and AB, respectively. The median survival time (MST) of patients with A alleles was shorter than that of patients with non-A alleles (p=0.048), especially among those who underwent resection (p=0.031). In contrast, no marked difference in the MST was noted among those who underwent chemotherapy and palliative care. Finally, a multivariate analysis confirmed A alleles as an independent factor associated with the long-term outcome of PC (p<0.05 in 2 different models).

Conclusion The ABO blood type influenced the long-term outcomes of Japanese patients with PC, presumably due to its impact on disease onset and tumor behavior.

Content from these authors
© 2020 by The Japanese Society of Internal Medicine
Next article
Favorites & Alerts

Recently viewed articles
Predecessor

Japanese Journal of Medicine

Share this page
feedback
 Top